Annals of internal medicine
-
Recent randomized controlled trials (RCTs) have investigated glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual or triple co-agonists for weight loss among adults with overweight or obesity and without diabetes. ⋯ None. (PROSPERO: CRD42024505558).
-
The evidence informing the harms of gabapentin use are at risk of bias from comparing users with nonusers. ⋯ None.
-
Dialysis patients have high rates of fracture morbidity, but evidence on optimal management strategies for osteoporosis is scarce. ⋯ None.